Uemura, Hirotsugu
Masumori, Naoya
Takahashi, Shunji
Hosono, Makoto
Kinuya, Seigo
Sunaya, Toshiyuki
Horio, Tomoyo
Okayama, Yutaka http://orcid.org/0000-0001-5242-1710
Kakehi, Yoshiyuki
Funding for this research was provided by:
Bayer Yakuhin, Ltd. (honoraria, honoraria, research funding, honoraria)
Pfizer (honoraria)
Janssen Pharmaceutical K.K., (honoraria)
Chugai Pharmaceutical Co. Ltd (honoraria, honoraria)
AstraZeneca (research funding, honoraria, honoraria, research funding)
Takeda Pharmaceutical Company (research funding)
Janssen Pharmaceutical K.K. (research funding, honoraria)
Ono Pharmaceutical (research funding)
Sanofi (research funding)
Daiichi Sankyo Co. Ltd. (research funding)
Bristol-Myers Squibb (honoraria, honoraria, research funding)
Taiho Pharmaceutical Co. Ltd. (research funding)
Kissei Pharmaceutical Co. Ltd (honoraria)
Takeda Pharmaceutical Co. Ltd. (honoraria)
Astellas Pharma Inc. (honoraria, research funding)
Ono Pharmaceutical Co. Ltd. (research funding, honoraria, research funding)
Merck Sharp & Dohme (honoraria, research funding)
Chugai Pharmaceutical Co. Ltd. (research funding)
Article History
Received: 4 September 2020
Accepted: 4 December 2020
First Online: 11 February 2021
Change Date: 9 March 2021
Change Type: Update
Change Details: Electronic Supplementary Material is included.
Compliance with ethical standards
:
: This study has been conducted by Bayer Yakuhin, Ltd. HU has received honoraria from Bayer Yakuhin, Ltd., Pfizer, Janssen Pharmaceutical K.K., Bristol-Myers Squibb, Merck Sharp & Dohme, and Chugai Pharmaceutical Co. Ltd, and research funding from AstraZeneca, Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co. Ltd., Sanofi, and Daiichi Sankyo Co. Ltd. NM has received honoraria from Kissei Pharmaceutical Co. Ltd, Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., and AstraZeneca, and research funding from Astellas Pharma Inc., and Ono Pharmaceutical Co. Ltd. ST has received honoraria from Bayer Yakuhin, Ltd., Merck Sharp & Dohme, AstraZeneca, Chugai Pharmaceutical Co. Ltd, Ono Pharmaceutical Co. Ltd., and Bristol-Myers Squibb, and research funding from Bayer Yakuhin, Ltd., Merck Sharp & Dohme, AstraZeneca, Chugai Pharmaceutical Co. Ltd, Ono Pharmaceutical Co. Ltd., and Bristol-Myers Squibb. MH has received honoraria from Bayer Yakuhin, Ltd. SK and YK declare no conflict of interest. TS, TH, and YO are employees of Bayer Yakuhin, Ltd.